Houlihan Lokey Advises Petauri
Houlihan Lokey is pleased to announce that Petauri, a leading purpose-built pharmaceutical services platform backed by Oak Hill Capital (Oak Hill), has acquired two U.K.-based firms: Mtech Access, a premier full-service global market access solutions provider, and Delta Hat, an experience-led company specializing in the technical aspects of evidence-based value demonstration. The terms of the transaction were not disclosed.
This announcement marks a pivotal moment in Petauri’s growth trajectory as the platform now numbers more than 300 global professionals, all dedicated to the vision of improving patient outcomes by speeding access to life-changing medical advances. The combined business will create a comprehensive suite of highly technical and specialized services that will deliver unparalleled value to Petauri clients globally.
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group—Powered by Petauri™ and FORCE Communications—Powered by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care.
Oak Hill is a longstanding private equity firm focused on the North American middle market. Oak Hill applies a specialized, theme-based approach to investing in the following dedicated industry sectors: media and communications, industrials, services, and consumer. The firm implements a highly systematic approach to theme development, proactive origination, and value creation in partnership with management to build franchises of lasting value. Over the past 35+ years, Oak Hill and its predecessors have raised approximately $20 billion of initial capital commitments and co-investments, invested in approximately 100 companies, and completed more than 300 add-on acquisitions, representing an aggregate enterprise value at the acquisition of over $60 billion.
Houlihan Lokey served as the exclusive financial advisor to Petauri and Oak Hill. This deal highlights Houlihan Lokey’s leading experience in the pharma commercialization space and represents the firm’s 24th transaction in this sector since 2019.
If you would like more information about Houlihan Lokey or have any questions regarding the firm’s role in this transaction, please contact one of the team members listed below.
RELATED: Marketing Services, Mergers & Acquisitions